Screening for Epidermal Growth Factor Receptor Mutations in Lung Cancer

This publication has 28 references indexed in Scilit:

• Somatic mutations affect key pathways in lung adenocarcinoma
  Nature, 2008
• Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer
  Cell, 2007
• Structures of Lung Cancer-Derived EGFR Mutants and Inhibitor Complexes: Mechanism of Activation and Insights into Differential Inhibitor Sensitivity
  Cancer Cell, 2007
• The impact of human EGFR kinase domain mutations on lung tumorigenesis and in vivo sensitivity to EGFR-targeted therapies
  Cancer Cell, 2006
• Lung adenocarcinomas induced in mice by mutant EGF receptors foundin human lung cancers respondto a tyrosine kinase inhibitor orto down-regulation of the receptors
  Genes & Development, 2006
• Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers
  JNCI Journal of the National Cancer Institute, 2005
• Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer
  Cancer Research, 2004
• EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
  Proceedings of the National Academy of Sciences, 2004
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
  Science, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004